|
|
||||||||
The Journal of Immunology, Vol 149, Issue 8 2541-2548, Copyright © 1992 by American Association of Immunologists
ARTICLES |
NK Damle, K Klussman, PS Linsley, A Aruffo and JA Ledbetter
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.
Although ligation of the CD3/TCR complex initiates an activation signal in T cells, additional costimulatory signals generated during cell-to- cell interactions with APC transduced via ligation of CD11a/CD18 and CD28 by their specific counter-receptor intercellular adhesion molecule (ICAM)-1 and B7, respectively, are required for optimal T cell proliferation and cytokine synthesis. Using soluble IgC gamma 1 fusion proteins of these costimulatory counter-receptors, we have recently shown that unactivated resting CD4+ T cells and Ag-primed CD4+ T cells differ in their response to the costimulation by ICAM-1 and B7. Preferential proliferative responses of resting T and Ag-primed T cells to ICAM-1 and B7, respectively, prompted us to speculate that ICAM-1- induced signals may regulate coupling of the CD28 signaling pathway. Furthermore, both B7 and ICAM-1 are co-expressed on APC and thus, may co-regulate activation-driven maturation of T cells. In this study, we have examined regulatory effects of IgC gamma 1 fusion proteins of B7, ICAM-1, and ICAM-2 (a homologue of ICAM-1) on each other's costimulation. We first demonstrate that TCR-directed costimulation of resting CD4+ T cells with ICAM-1 (ICAM-1 priming) but not ICAM-2 induces increased responsiveness to B7. Priming of CD4+ T cells with ICAM-1 induced higher expression of both CD18 and CD28 than that with either B7 or ICAM-2. Cross-linking of CD28 induced faster and significantly higher cytoplasmic free calcium mobilization response in ICAM-1-primed CD4+ T cells than in resting, B7-primed, or ICAM-2-primed CD4+ T cells. B7 synergized with ICAM-1 but not ICAM-2 to augment proliferative responses of not only resting CD4+ T cells but also those that had been primed with either ICAM. Unlike resting or ICAM-2-primed CD4+ T cells, ICAM-1-primed CD4+ T cells efficiently proliferated in response to the synergistic costimulation of B7 and ICAM-2. In contrast, both ICAM-1 and ICAM-2 inhibit B7-driven proliferation of Ag- primed CD4+ T cells. Thus, B7 and ICAM-1 exert contrasting regulatory effects on the proliferation of CD4+ T cells depending on their state of activation-induced maturation.
This article has been cited by other articles:
![]() |
S. Clare, R. Goldin, C. Hale, R. Aspinall, C. Simmons, P. Mastroeni, and G. Dougan Intracellular Adhesion Molecule 1 Plays a Key Role in Acquired Immunity to Salmonellosis Infect. Immun., October 1, 2003; 71(10): 5881 - 5891. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kunitomi, T. Hori, A. Imura, and T. Uchiyama Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system J. Leukoc. Biol., July 1, 2000; 68(1): 111 - 118. [Abstract] [Full Text] |
||||
![]() |
K. Scharffetter-Kochanek, H. Lu, K. Norman, N. van Nood, F. Munoz, S. Grabbe, M. McArthur, I. Lorenzo, S. Kaplan, K. Ley, et al. Spontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice J. Exp. Med., July 1, 1998; 188(1): 119 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Isobe, J.-i. Suzuki, S. Yamazaki, Y. Yazaki, S. Horie, Y. Okubo, K. Maemura, Y. Yazaki, and M. Sekiguchi Regulation by Differential Development of Th1 and Th2 Cells in Peripheral Tolerance to Cardiac Allograft Induced by Blocking ICAM-1/LFA-1 Adhesion Circulation, October 7, 1997; 96(7): 2247 - 2253. [Abstract] [Full Text] |
||||
![]() |
Y. Chen, P. G. Schlegel, N. Tran, D. Thompson, J. L. Zehnder, and N. J. Chao Administration of a CD31-Derived Peptide Delays the Onset and Significantly Increases Survival From Lethal Graft-Versus-Host Disease Blood, February 15, 1997; 89(4): 1452 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Shahinian, K Pfeffer, K. Lee, T. Kundig, K Kishihara, A Wakeham, K Kawai, P. Ohashi, C. Thompson, and T. Mak Differential T cell costimulatory requirements in CD28-deficient mice Science, July 30, 1993; 261(5121): 609 - 612. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |